The forthcoming Vall d´Hebron Institute of Oncology (VHIO) two-day Special Symposium on Towards Predictive Cancer Models, 26 – 27 May, 2016, Barcelona, Spain, has been expertly engineered to bring together an expert panel of internationally acclaimed speakers who will present and debate on and around the five especially selected sessions:

1) Cancer Immunology and Tumour Microenvironment,

2) New Prospectives,

3) Circumventing Therapy Resistance,

4) Redefining the Targets, and

5) New Opportunities from Human Tumour Samples: Explants, Organoids, and PDX.

Interspersed throughout the programme we will also learn from, and interact with, our trio of keynote presenters, Lisa Coussens (USA), Scott Lowe (USA), and Mariano Barbacid (Spain), who will deliver the very latest discovery into complex interactions between immune system machinery and the dominant force in multi-drug resistance – the tumour microenvironment, crucial insights into cancer drivers provided by modelling cancer using non-germline GEMMS, as well as evidencing the necessity of modelling K-Ras tumours in mouse models as the test-bed for developing future therapies, respectively.

In addition to the main scientific programme, we can also expect to discover yet more relevant and recent advances in predictive cancer science throughout the poster and networking sessions twinned throughout the two lunch breaks.

Posters will be divided and displayed across these sessions with their respective author(s) present to discuss their data directly with us all. Following directly after lunch, prior to kicking off the next main symposium session, there will be three invited short talks selected from among the abstracts received.